178 related articles for article (PubMed ID: 21292754)
41. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J
Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143
[TBL] [Abstract][Full Text] [Related]
42. Outcome of surgical resection for pathologic N0 and Nx non-small cell lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; Spencer D; O'Brien T
J Thorac Oncol; 2010 Feb; 5(2):191-6. PubMed ID: 20035237
[TBL] [Abstract][Full Text] [Related]
43. The number of resected lymph nodes (nLNs) combined with tumor size as a prognostic factor in patients with pathologic N0 and Nx non-small cell lung cancer.
Yang M; Cao H; Guo X; Zhang T; Hu P; Du J; Liu Q
PLoS One; 2013; 8(9):e73220. PubMed ID: 24023836
[TBL] [Abstract][Full Text] [Related]
44. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study.
Hao Y; Li G
Eur J Cancer Prev; 2023 Sep; 32(5):498-511. PubMed ID: 36804864
[TBL] [Abstract][Full Text] [Related]
45. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.
Zhou X; Wu C; Cheng Q
Lung; 2020 Oct; 198(5):839-846. PubMed ID: 32683563
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
47. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
[TBL] [Abstract][Full Text] [Related]
48. Prognostic and Predictive Effects of Positive Lymph Node Number or Ratio in NSCLC.
Ding N; Pang Z; Zhang X; Huang C; Yang Y; Liu Q; Du J
Sci Rep; 2017 Apr; 7(1):584. PubMed ID: 28373661
[TBL] [Abstract][Full Text] [Related]
49. T1/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter?
Whitson BA; Groth SS; Andrade RS; Habermann EB; Maddaus MA; D'Cunha J
J Surg Res; 2012 Oct; 177(2):185-90. PubMed ID: 22921916
[TBL] [Abstract][Full Text] [Related]
50. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
51. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
52. Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.
Benlloch S; Galbis-Caravajal JM; Alenda C; Peiró FM; Sanchez-Ronco M; Rodríguez-Paniagua JM; Baschwitz B; Rojas E; Massutí B
Ann Oncol; 2009 Jan; 20(1):91-7. PubMed ID: 18664559
[TBL] [Abstract][Full Text] [Related]
53. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J
Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012
[TBL] [Abstract][Full Text] [Related]
54. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
[TBL] [Abstract][Full Text] [Related]
55. Change of junctions between stations 10 and 4 in the new International Association for the Study of Lung Cancer Lymph Node Map: a validation study from a single, tertiary referral hospital experience.
Lee S; Lee HY; Lee KS; Yie M; Zo J; Shim YM; Han J; Ahn JH
Chest; 2015 May; 147(5):1299-1306. PubMed ID: 25275253
[TBL] [Abstract][Full Text] [Related]
56. Clinical implications of uncertain resection in scenarios of metastasis of the highest or most distant mediastinal lymph node station following surgical treatment of non-small-cell lung cancer.
Park SY; Byun GE; Lee CY; Lee JG; Kim DJ; Paik HC; Chung KY
Lung Cancer; 2019 Dec; 138():1-5. PubMed ID: 31593893
[TBL] [Abstract][Full Text] [Related]
57. Lymph node ratio is a prognostic factor for non-small cell lung cancer.
Sun G; Xue L; Wang M; Zhao X
Oncotarget; 2015 Oct; 6(32):33912-8. PubMed ID: 26393881
[TBL] [Abstract][Full Text] [Related]
58. Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report.
Isaka M; Kondo H; Maniwa T; Takahashi S; Ohde Y
J Thorac Oncol; 2016 Jul; 11(7):1176-80. PubMed ID: 27058910
[TBL] [Abstract][Full Text] [Related]
59. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
60. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
